Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
5.76
31.22
542.01%
Share Warrants & Outstandings
Total Reserve
-62.01
63.00
-125.01
-198.43%
Shareholder's Funds
-25.02
68.76
-93.78
-136.39%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
21.52
0.00
21.52
0.00%
Secured Loans
2.63
0.00
2.63
0.00%
Unsecured Loans
18.89
0.00
18.89
0.00%
Deferred Tax Assets / Liabilities
-10.80
1.06
-11.86
-1,118.87%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.08
0.20
0.88
440.00%
Total Non-Current Liabilities
11.80
1.26
10.54
836.51%
Current Liabilities
Trade Payables
29.79
15.15
14.64
96.63%
Other Current Liabilities
15.11
0.68
14.43
2,122.06%
Short Term Borrowings
40.71
0.98
39.73
4,054.08%
Short Term Provisions
0.23
0.11
0.12
109.09%
Total Current Liabilities
85.85
16.92
68.93
407.39%
Total Liabilities
72.62
86.94
-14.32
-16.47%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
61.50
38.04
23.46
61.67%
Less: Accumulated Depreciation
21.87
18.38
3.49
18.99%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
39.63
19.66
19.97
101.58%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.23
0.00
0.23
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.35
-0.30
-85.71%
Long Term Loans & Advances
0.68
0.00
0.68
0.00%
Other Non Current Assets
1.08
0.18
0.90
500.00%
Total Non-Current Assets
41.68
20.19
21.49
106.44%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
20.51
7.39
13.12
177.54%
Sundry Debtors
5.10
14.18
-9.08
-64.03%
Cash and Bank
0.12
31.16
-31.04
-99.61%
Other Current Assets
4.58
10.23
-5.65
-55.23%
Short Term Loans and Advances
0.63
3.79
-3.16
-83.38%
Total Current Assets
30.94
66.75
-35.81
-53.65%
Net Current Assets (Including Current Investments)
-54.90
49.83
-104.73
-210.17%
Total Current Assets Excluding Current Investments
30.94
66.75
-35.81
-53.65%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
72.62
86.94
-14.32
-16.47%
Contingent Liabilities
2.91
0.29
2.62
903.45%
Total Debt
62.23
0.98
61.25
6,250.00%
Book Value per share (adjusted)
-6.77
117.14
-123.91
-105.78%
Annual - Borrowings
Borrowings 62.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 39.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 30.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024






